Newest Titles

• Entwicklung und Charakterisierung eines kleinformatigen 177 Lu-Radioimmunkonjugats zur Therapie von CD22-positiven Lymphomen und Leukämien
  Book/Monograph, Thesis
• High treatment efficacy by dual targeting of Burkitt’s lymphoma xenografted mice with a 177Lu-based CD22-specific radioimmunoconjugate and rituximab
  Article (Journal), Online Resource
• Preclinical evaluation of a diabody-based 177Lu-radioimmunoconjugate for CD22-directed radioimmunotherapy in a non-Hodgkin lymphoma mouse model
  Article (Journal), Online Resource
• A humanized anti-CD22-onconase antibody-drug conjugate mediates highly potent destruction of targeted tumor cells
  Article (Journal), Online Resource
• An EGF receptor targeting Ranpirnase-diabody fusion protein mediates potent antitumour activity in vitro and in vivo: Stefan Kiesgen, Michaela A.E. Arndt, Christoph Körber, Ulrich Arnold, Tobias Weber, Niels Halama, Armin Keller, Benedikt Bötticher, Anne Schlegelmilch, Nora Liebers, Martin Cremer, Christel Herold-Mende, Gerhard Dyckhoff, Philippe A. Federspil, Alexandra D. Jensen, Dirk Jäger, Roland E. Kontermann, Walter Mier, Jürgen Krauss
  Article (Journal), Online Resource

see all (7)

Related Authors

• Jäger, Dirk
• Krauß, Jürgen
• Arndt, Michaela
• Mier, Walter
• Dyckhoff, Gerhard

see all (30)

Publication Timeline

Publication Formats